Riley Wyberg

ID: 1b826635-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA Approves Genentech’s GAZYVA® (obinutuzumab)

Big Molecule Watch · October 30, 2025

Teva and Prestige Biopharma Enter Licensing Agreement to Commercialize Their Trastuzumab Biosimilar

Big Molecule Watch · October 30, 2025

FDA Approves Celltrion’s Aflibercept Biosimilar

Big Molecule Watch · October 14, 2025

Sandoz and Regeneron Settle Aflibercept BPCIA Case

Big Molecule Watch · September 11, 2025

Final Judgment of Non-Infringement Entered in Alnylam v. Pfizer Vaccine Patent Dispute

Big Molecule Watch · August 5, 2025